Davita - Owensboro Dialysis Center is a medicare approved dialysis facility center in Owensboro, Kentucky and it has 25 dialysis stations. It is located in Daviess county at 1930 East Parrish Avenue, Owensboro, KY, 42303. You can reach out to the office of Davita - Owensboro Dialysis Center at (270) 926-0120. This dialysis clinic is managed and/or owned by Davita. Davita - Owensboro Dialysis Center has the following ownership type - Profit. It was first certified by medicare in August, 2000. The medicare id for this facility is 182547 and it accepts patients under medicare ESRD program.
| Name | Davita - Owensboro Dialysis Center |
|---|---|
| Location | 1930 East Parrish Avenue, Owensboro, Kentucky |
| No. of Dialysis Stations | 25 |
| Medicare ID | 182547 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1930 East Parrish Avenue, Owensboro, Kentucky, 42303 | |
| (270) 926-0120 | |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
| NPI Number | 1730149170 |
| Organization Name | Owensboro Dialysis Center |
| Doing Business As | Renal Treatment Centers Illinois Inc |
| Address | 1930 E Parrish Ave Owensboro, Kentucky, 42303 |
| Phone Number | (270) 926-0120 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 71% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 12% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 17% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 68% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 14% |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 70% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 21% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 9% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 74% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 21% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 82% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 18% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 73% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 12% |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 54 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 17 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 101 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 820 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
| Adult patients getting regular peritoneal dialysis at the center | 6 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 55 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Owensboro Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 110 |
| Hypercalcemia patient months | 911 |
| Patients with Serumphosphor | 121 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 31 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 36 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 87 |
| Patient months included in arterial venous fistula and catheter summaries | 629 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 73 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 5 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 99 |
| Hospitalization Rate in facility | 195.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 305.7 |
| Hospitalization Rate: Lower Confidence Limit | 127.6 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Owensboro Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 31.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 42.3 |
| Readmission Rate: Lower Confidence Limit | 21.7 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Owensboro Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .24 (As Expected) |
| SIR: Upper Confidence Limit | 1.17 |
| SIR: Lower Confidence Limit | .01 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Owensboro Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 85 |
| Transfusion Rate in facility | 41.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 87.2 |
| Transfusion Rate: Lower Confidence Limit | 21.9 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Owensboro Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 525 |
| Mortality Rate in facility | 20.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.6 |
| Mortality Rate: Lower Confidence Limit | 16.8 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago
Davita - Owensboro Dialysis Center Location: 1930 East Parrish Avenue, Owensboro, Kentucky, 42303 Phone: (270) 926-0120 |
Davita - Owensboro Home Dialysis Location: 3250 Kidron Valley Way, Owensboro, Kentucky, 42303 Phone: (270) 691-9605 |
News Archive
Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes ("NHSCSP") has approved the use of the BD FocalPoint "No Further Review" technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.
One in six women arriving at orthopedic fracture clinics have been victims of physical, emotional, or sexual violence at the hands of an intimate partner within the past year, and one in 50 arrive as a direct result of intimate partner violence (IPV), according to the largest multinational study of its kind to date, led by McMaster University researchers.
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 4 days ago